The RESTART project: high-dose atorvastatin helps control RESTenosis AfteR sTenting procedures at high risk for restenosis. Results from a prospective study and a matched control group comparison

Francesco Prati1*, MD; Fabrizio Imola1, MD; Pierfrancesco Corvo1, MD; Carmelo Cernigliaro2, MD; Tamer Fouadi1, BsC; Vito Ramazzotti1, MD; Alessandro Manzoli1, MD; Alessandro Pappalardo1, MD; Maria Cera1, MD

1. Cath Lab, Ospedale San Giovanni-Addolorata, Rome, Italy; 2. Department of Cardiology, Ospedale Maggiore della Carità, Novara, Italy

Aims: The long-term results of bare stenting in complex procedures are troubled by a high incidence of restenosis. The use of drug-eluting stents lead to excellent long-term angiographic re

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

restenosisstentsrevascularisationatorvastatin

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Framework towards optimisation of bone marrow stem cells therapy for cardiac repair